Mateusz Kaczmarek

Mateusz Kaczmarek is a financial and technology journalist at TS2.tech, covering stocks, artificial intelligence, semiconductors and global market developments. A graduate of the Poznań University of Economics and Business, he previously worked in financial analysis before moving into business journalism. His reporting focuses on technology companies, market trends and the forces shaping global investment markets. Follow Mateusz Kaczmarek on Google News.

Paysafe (PSFE) Tumbles After Q3 2025 Earnings Miss, Guidance Cut and New Endava AI Partnership

Paysafe (PSFE) Tumbles After Q3 2025 Earnings Miss, Guidance Cut and New Endava AI Partnership

London / New York – November 13, 2025 — Paysafe Limited is in the spotlight today after releasing its third‑quarter 2025 results, slashing its full‑year outlook and unveiling a new multi‑year AI‑driven payments partnership with Endava. The mixed update has triggered a sharp sell‑off in PSFE stock despite solid underlying revenue growth. Stock Titan+2
13 November 2025
Sonder Holdings (SOND) Nears Chapter 7 After Marriott Split: Stock & Bankruptcy Update for November 13, 2025

Sonder Holdings (SOND) Nears Chapter 7 After Marriott Split: Stock & Bankruptcy Update for November 13, 2025

Sonder Holdings Inc., once pitched as a tech‑driven rival to Airbnb and a partner of Marriott International, is now in full collapse mode. The company is winding down operations, expecting to file for Chapter 7 bankruptcy of its U.S. business and begin insolvency proceedings abroad, while guests around the world report being told to leave their rooms with only hours’ notice. 6abc Philadelphia+3Yahoo Finance+3Stock Titan+3
13 November 2025
Xbox Cloud Gaming Officially Launches in India: Prices, Devices, and How to Play Without an Xbox Console (November 13, 2025)

Xbox Cloud Gaming Officially Launches in India: Prices, Devices, and How to Play Without an Xbox Console (November 13, 2025)

Microsoft has finally flipped the switch on Xbox Cloud Gaming in India, turning millions of phones, PCs and TVs into instant Xbox machines — no console required. The service, bundled with the revamped Xbox Game Pass tiers, quietly launched on November 11, 2025, making India the 29th market to officially support Xbox’s cloud streaming platform. Moneycontrol
13 November 2025
Mangoceuticals (MGRX) Soars on Eli Lilly and Novo Nordisk Deal as It Launches MangoRx Direct for Obesity Drugs

Mangoceuticals (MGRX) Soars on Eli Lilly and Novo Nordisk Deal as It Launches MangoRx Direct for Obesity Drugs

Mangoceuticals, Inc., the tiny telehealth company best known for its MangoRx men’s wellness brand, is suddenly at the center of the red‑hot obesity drugs market after unveiling a partnership with Eli Lilly and Novo Nordisk to offer official access to their blockbuster GLP‑1 weight‑loss medications Zepbound and Wegovy.GlobeNewswire+1
Stratasys (SSYS) Q3 2025 Earnings: Revenue Slips, Cash Flow Strengthens as 3D Printing Leader Reaffirms 2025 Outlook

Stratasys (SSYS) Q3 2025 Earnings: Revenue Slips, Cash Flow Strengthens as 3D Printing Leader Reaffirms 2025 Outlook

Stratasys Ltd., a leading player in polymer 3D printing and additive manufacturing, reported third-quarter 2025 results this morning that paint a mixed picture: modestly lower revenue, a sharply wider GAAP loss driven by a non‑cash impairment, but improved cash generation and reaffirmed full‑year guidance. Business Wire+2Business Wire+2
Bitfarms (BITF) Stock Slips After Q3 2025 Miss as AI & HPC Pivot Kicks Into High Gear

Bitfarms (BITF) Stock Slips After Q3 2025 Miss as AI & HPC Pivot Kicks Into High Gear

Bitfarms Ltd. delivered a big strategic update alongside its third‑quarter 2025 results on November 13, 2025, revealing booming revenue growth but a wider loss and a notable miss versus Wall Street expectations. At the same time, the company doubled down on its transformation from a Bitcoin miner into a high‑performance computing and AI infrastructure provider, unveiling a major plan to convert its Washington State facility for next‑gen Nvidia GPUs. GlobeNewswire+1
Korro Bio (KRRO) Stock Crashes as Novo Nordisk Pauses Pact, KRRO‑110 Disappoints and 34% Layoffs Extend Cash Runway – What Investors Need to Know Today

Korro Bio (KRRO) Stock Crashes as Novo Nordisk Pauses Pact, KRRO‑110 Disappoints and 34% Layoffs Extend Cash Runway – What Investors Need to Know Today

Korro Bio, Inc. is at the center of one of biotech’s biggest shake‑ups of 2025. After releasing mixed early data from its lead RNA‑editing program, KRRO‑110, the company has announced deep layoffs, a strategic pivot in its pipeline and a 12‑month pause in its high‑profile collaboration with Novo Nordisk. The stock has responded with a brutal collapse.
13 November 2025
MP Materials Stock on Fire: $100 Would Be $329 Today – But Is This the Next Nvidia?

MP Materials Stock on Fire: $100 Would Be $329 Today – But Is This the Next Nvidia?

MP Materials, America’s only fully integrated rare earths producer, is back in the spotlight today as Wall Street debates a bold question: could this little-known mining company be the “next Nvidia”? At the same time, fresh analysis shows a $100 investment in MP just one year ago would now be worth about $329, underscoring how explosive the stock’s 2025 rally has been. investors.mpmaterials.com+1
OnePlus 15 Global Launch Today: 7,300mAh ‘Marathon’ Battery, No Magnets, and a New Direction for the Brand

OnePlus 15 Global Launch Today: 7,300mAh ‘Marathon’ Battery, No Magnets, and a New Direction for the Brand

The OnePlus 15 is stepping onto the global stage today, and it’s doing so with a very loud flex: an enormous 7,300mAh battery, 120W charging, a 165Hz display, and a bold decision to skip built‑in magnetic charging altogether. At the same time, OnePlus is quietly reinventing itself with flatter, tougher hardware and an AI‑first software experience that has fans split over whether the company has “lost its way” or finally grown up. TechRadar+3The Hans India+3Android Authority+3
13 November 2025
Mersana Therapeutics (MRSN) Soars on Up to $285 Million Day One Biopharmaceuticals Buyout: All the Key News on November 13, 2025

Mersana Therapeutics (MRSN) Soars on Up to $285 Million Day One Biopharmaceuticals Buyout: All the Key News on November 13, 2025

Mersana Therapeutics is back in the headlines in a big way today after announcing a definitive agreement to be acquired by Day One Biopharmaceuticals in a deal worth up to approximately $285 million. The news has sent MRSN shares rocketing higher and triggered immediate legal and regulatory attention, making this one of the most closely watched biotech deals of the day. GlobeNewswire
1 52 53 54 55 56 164

Stock Market Today

  • Bull-Dog Sauce (TSE:2804) Q1 Results Show Margin Drop as One-Off Impact Fades
    July 25, 2026, 4:52 PM EDT. Bull-Dog Sauce posted first-quarter 2027 revenue of ¥3.7b and net profit of ¥601m, as earnings per share slipped to ¥47.66 from last year's ¥135.30. The net profit margin slid from 16.2% to 8.7%, reflecting the absence of a previous ¥913m one-off gain. Over the past 12 months, net profit was ¥1,276m, down from ¥2,375m. Shares last changed hands at ¥1,831, giving a P/E of 18.1x and dividend yield of 2.46%, underscoring worries about profit momentum relative to a lofty valuation.